Certain clinical and imaging features derived from ALK/ROS1/RET fusion-positive lung adenocarcinoma patients were found to be good discriminators of fusion-positive and fusion- negative lung adenocarcinomas. Here, ROS1 is linked to lung adenocarcinoma.